Amarantus Biosciences Announces the Release of Research Report by TomorrowsBlueChips.com
Sunnyvale, CA - Amarantus BioSciences Inc. (OTCBB: AMBS), a California-based biotechnology company focused on the development of a therapeutic protein known as MANF, announced today that TomorrowsBlueChips.com has profiled it in a 9-page research report that can be found directly on the web site under its Research section: http://tomorrowsbluechips.com/research/ The report’s analysis states, “Amarantus is now exposed to two global markets: Parkinson’s and Traumatic Brain Injury.” It adds that “Amarantus is interested in partnering opportunities for its product candidates that will allow